INmune Bio Stock Forward View - Price Action Indicator
| INMB Stock | USD 1.56 0.05 3.11% |
INmune Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast INmune Bio stock prices and determine the direction of INmune Bio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of INmune Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of INmune Bio's share price is approaching 45. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling INmune Bio, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (1.25) | EPS Estimate Next Year (0.99) | Wall Street Target Price 5.25 | Quarterly Revenue Growth 2.571 |
Using INmune Bio hype-based prediction, you can estimate the value of INmune Bio from the perspective of INmune Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards INmune Bio using INmune Bio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards INmune using crowd psychology based on the activity and movement of INmune Bio's stock price.
INmune Bio Implied Volatility | 1.91 |
INmune Bio's implied volatility exposes the market's sentiment of INmune Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if INmune Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that INmune Bio stock will not fluctuate a lot when INmune Bio's options are near their expiration.
INmune Bio after-hype prediction price | USD 1.56 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of INmune Bio to cross-verify your projections. Prediction based on Rule 16 of the current INmune contract
Based on the Rule 16, the options market is currently suggesting that INmune Bio will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-03-20 option contract. With INmune Bio trading at USD 1.56, that is roughly USD 0.001862 . If you think that the market is fully incorporating INmune Bio's daily price movement you should consider acquiring INmune Bio options at the current volatility level of 1.91%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 INmune Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast INmune Bio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in INmune Bio's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for INmune Bio stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current INmune Bio's open interest, investors have to compare it to INmune Bio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of INmune Bio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in INmune. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
INmune Bio Additional Predictive Modules
Most predictive techniques to examine INmune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INmune using various technical indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.16) | (0.04) |
| Check INmune Bio Volatility | Backtest INmune Bio | Information Ratio |
INmune Bio Trading Date Momentum
| On January 29 2026 INmune Bio was traded for 1.56 at the closing time. The top price for the day was 1.60 and the lowest listed price was 1.56 . The trading volume for the day was 122.7 K. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.92% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare INmune Bio to competition |
Other Forecasting Options for INmune Bio
For every potential investor in INmune, whether a beginner or expert, INmune Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. INmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in INmune. Basic forecasting techniques help filter out the noise by identifying INmune Bio's price trends.INmune Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INmune Bio stock to make a market-neutral strategy. Peer analysis of INmune Bio could also be used in its relative valuation, which is a method of valuing INmune Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
INmune Bio Market Strength Events
Market strength indicators help investors to evaluate how INmune Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INmune Bio shares will generate the highest return on investment. By undertsting and applying INmune Bio stock market strength indicators, traders can identify INmune Bio entry and exit signals to maximize returns.
INmune Bio Risk Indicators
The analysis of INmune Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in INmune Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inmune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.65 | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.37 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for INmune Bio
The number of cover stories for INmune Bio depends on current market conditions and INmune Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INmune Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INmune Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
INmune Bio Short Properties
INmune Bio's future price predictability will typically decrease when INmune Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of INmune Bio often depends not only on the future outlook of the potential INmune Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INmune Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.9 M | |
| Cash And Short Term Investments | 20.9 M |
Check out Historical Fundamental Analysis of INmune Bio to cross-verify your projections. For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. Market participants price INmune higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive INmune Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.08) | Revenue Per Share | Quarterly Revenue Growth 2.571 | Return On Assets | Return On Equity |
INmune Bio's market price often diverges from its book value, the accounting figure shown on INmune's balance sheet. Smart investors calculate INmune Bio's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since INmune Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.